2011-08-04T16:27:18-05:00 2010-12-31 WINDES & MCCLAUGHRY ACCT CORP PO BOX 87 LONG BEACH CA 908010087 990 2010-01-01 261636099 MELANOMA RESEARCH ALLIANCE FOUNDATION MELA 2023368935 1101 NEW YORK AVE NW NO 620 WASHINGTON DC 20005 WENDY SELIG 2023368935 2011-08-03 1 BRIAN D YACKER 5624351191 2010 2016-02-24 21:20:13Z WENDY SELIG 1101 NEW YORK AVE NW NO 620 WASHINGTON DC 20005 24046256 0 X WWW.MELANOMARESEARCHALLIANCE.ORG X 2007 DE TO ACCELERATE SCIENTIFIC DISCOVERY TO ELIMINATE SUFFERING AND DEATH DUE TO MELANOMA. 15 14 0 50 0 0 6533950 23589185 0 0 8718 25642 0 0 6542668 23614827 5774997 7856932 0 0 338613 567410 0 0 197456 883992 765646 6997602 9189988 -454934 14424839 2243638 16707780 64826 104679 2178812 16603101 X TO ACCELERATE THE PACE OF SCIENTIFIC DISCOVERY, ULTIMATELY TO FIND A CURE BY FUNDING THE MOST PROMISING MELANOMA RESEARCH WORLDWIDE THAT WILL IMPROVE OUTCOMES FOR PATIENTS AND ALL WHO ARE AT RISK. 0 0 8642083 7856932 THE MELANOMA RESEARCH ALLIANCE FOUNDATION ("MRAF") SUPPORTS AMBITIOUS AND INNOVATIVE PROJECTS, INITIATED BY INDIVIDUAL SCIENTISTS AND SCIENCE RESEARCH TEAMS, TO DEVELOP NOVEL DIAGNOSTIC AND THERAPEUTIC AVENUES RELEVANT TO PATHWAYS GOVERNING THE BEHAVIOR AND CLINICAL OUTCOME OF MELANOMA.MRAF CONVENES A WORLD-CLASS, CROSS-DISCIPLINARY GROUP OF EXPERT BIOMEDICAL RESEARCHERS POSSESSING CLINICAL AND SCIENTIFIC EXPERTISE TO DEVELOP A RESEARCH AGENDA THAT WILL PROVIDE INNOVATIVE SOLUTIONS TO CRITICAL RESEARCH ISSUES LEADING TO BETTER TREATMENTS AND A CURE FOR MELANOMA. MRAF MAKES GRANTS TO DOMESTIC RESEARCH UNIVERSITIES, MEDICAL SCHOOLS, AND NONPROFIT MEDICAL RESEARCH ORGANIZATIONS DIRECTLY INVOLVED IN DETERMINING THE CAUSES AND CURES OF MELANOMA ON THE CONDITION THAT SUCH RESEARCH BE MADE AVAILABLE TO THE SCIENTIFIC COMMUNITY. MRAF ALSO MAKES GRANTS TO SCIENTISTS AND MEDICAL RESEARCHERS AND MAKES GRANTS TO FOREIGN RESEARCH UNIVERSITIES, MEDICAL SCHOOLS, AND MEDICAL RESEARCH ORGANIZATIONS. 8642083 1 1 0 1 0 0 0 0 0 1 0 0 0 1 0 0 1 0 0 1 1 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 1 1 1 0 0 0 1 0 0 0 0 1 13 0 1 0 0 0 0 0 0 1 1 0 0 0 0 X 15 14 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 AL AK AZ AR CA CO CT FL HI IL KS KY LA ME MD MI MN NJ NM NY NC ND WI OR OK OH UT TN SC RI PA WV WA VA X KAMYAB HASHEMI-NEJAD 3105704612 1250 FOURTH STREET SANTA MONICA CA 90401 DEBRA BLACK 10.00 X X 0 0 0 LEON BLACK 1.00 X 0 0 0 MARIA BELL 1.00 X 0 0 0 JASON FEDERICI 1.00 X 0 0 0 JAMI GERTZ 1.00 X 0 0 0 SUSAN HESS 1.00 X 0 0 0 MICHAEL KLOWDEN 2.00 X 0 419861 11823 NANCY MARKS 1.00 X 0 0 0 MICHAEL MILKEN 1.00 X 0 0 0 RICHARD RESSLER 1.00 X 0 0 0 HENRY SILVERMAN 1.00 X 0 0 0 GREGORY SIMON 1.00 X 0 0 0 JONATHAN SIMONS 1.00 X 0 0 0 JONATHAN SOKOLOFF 1.00 X 0 0 0 ELIZABETH STANTON 1.00 X 0 0 0 WENDY SELIG 40.00 X 232888 0 12161 KAMYAB HASHEMI-NEJAD 10.00 X 0 150180 10647 232888 570041 34631 1 0 1 0 0 5031493 18557692 1340377 23589185 25642 25642 431429 5031493 431429 0 23614827 0 0 25642 6596931 6596931 1260001 1260001 245049 110272 83317 51460 277065 124679 96446 55940 19576 8809 6796 3971 25720 11574 8858 5288 16413 7758 5420 3235 40575 40575 207717 155732 32552 19433 13435 10990 1531 914 7377 3600 2365 1412 58708 46136 7872 4700 139591 65970 46100 27521 86698 72821 8690 5187 159949 159949 2119 953 730 436 9785 4403 3370 2012 STATE FILING FEES 15260 15260 BANK CHARGES 4677 4677 MISCELLANEOUS 3342 1505 1150 687 9189988 8642083 350449 197456 416603 931130 1811918 5730021 9468362 10000 17846 8154 2758 5117 5396 0 555025 2243638 16707780 54478 59717 25000 10348 19962 64826 104679 X 2178812 5749739 10853362 2178812 16603101 2243638 16707780 X 14424839 -550 X 0 1 1 X 0 X X X X 0 0 0 THE MILKEN INSTITUTE 954240775 7 1 1 1 0 1 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 4500 4500 8835769 8840269 592013 148003 0 0 592013 592013 888020 4500 4500 148003 148003 222005 8154 2758 5396 5396 DUE TO MILKEN INSTITUTE/FASTERCURES 10282 DEFERRED RENT 9680 19962 23614827 9189988 14424839 -550 -550 14424289 23707634 0 23707634 -92807 -92807 23614827 9282794 92807 92807 9189987 0 9189987 PART XII, LINE 4B - OTHER ADJUSTMENTS: SPECIAL EVENT EXPENSES -92,807. PART XIII, LINE 2D - OTHER ADJUSTMENTS: SPECIAL EVENT EXPENSES 92,807. 1 EAST ASIA AND THE PACIFIC 0 0 GRANTS TO RESEARCH ORGANIZATIONS LOCATED IN REGION 1000001 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTS TO RESEARCH ORGANIZATIONS LOCATED IN REGION 97500 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTS TO RESEARCH ORGANIZATIONS LOCATED IN REGION 162500 0 0 0 1260001 0 1260001 EAST ASIA AND THE PACIFIC TEAM SCIENCE AWARD 666667 CHECK EAST ASIA AND THE PACIFIC TEAM SCIENCE AWARD 333334 CHECK MIDDLE EAST AND NORTH AFRICA ESTABLISHED INVESTIGATOR AWARD 112500 CHECK MIDDLE EAST AND NORTH AFRICA YOUNG INVESTIGATOR AWARD 50000 CHECK EUROPE (INCLUDING ICELAND & GREENLAND) YOUNG INVESTIGATOR AWARD 50000 CHECK EUROPE (INCLUDING ICELAND & GREENLAND) YOUNG INVESTIGATOR AWARD 47500 CHECK 6 0 0 0 0 0 0 0 PROCEDURE FOR MONITORING GRANTS OUTSIDE THE U.S.: SCHEDULE F, PART I, LINE 2: EACH PROPOSAL TO THE MRA IS REVIEWED FOR SCIENTIFIC MERIT AND TRANSLATIONAL AND CLINICAL IMPACT BY MRA'S WORLD-CLASS GRANT REVIEW COMMITTEE (GRC). CRITERIA ARE DESCRIBED IN THE MRA'S REQUEST FOR PROPOSALS, GRC MEMBERS ARE SENIOR THOUGHT-LEADERS IN MELANOMA AND CANCER RESEARCH. AFTER A SCIENTIFIC PEER REVIEW BY THE GRC, THE MRA BOARD OF DIRECTORS APPROVES FINAL RESEARCH AWARDS FOR FUNDING. RESEARCH AND AWARD FUNDS ARE DISPENSED ON AN ANNUAL BASIS, CONTINGENT UPON MRA STAFF REVIEW OF ANNUAL PROGRESS REPORTS SUBMITTED BY THE GRANTEES. AWARDEES PROVIDE MRA WITH ANNUAL WRITTEN REPORTS OF THEIR RESEARCH PROGRESS AND COMPLIANCE WITH BUDGET GUIDELINES. FUNDS ARE DISTRIBUTED IN ANNUAL INSTALLMENTS AND NEXT YEAR'S INSTALLMENT IS NOT PROVIDED UNTIL SATISFACTORY REVIEW BY THE MRA CHIEF SCIENCE OFFICER AND SCIENTIFIC PROGRAM DIRECTOR. AWARDEES MUST KEEP SYSTEMATIC AND COMPLETE RECORDS ON THE RECEIPT AND DISBURSEMENT OF ALL AWARD FUNDS, AND MAY NOT CO-MINGLE ANY FUNDS FROM OTHER SOURCES. BENEFIT DINNER EVENT 5462922 5031493 431429 329410 49550 52469 5462922 5031493 431429 329410 49550 52469 431429 0 1 MEMORIAL SLOAN-KETTERING CANCER INSTITUTE 1275 YORK AVENUE NEW YORK NY 10021 131924236 501(C)(3) 1249999 TEAM SCIENCE AWARDS UNIVERSITY OF VIRGINIA HEALTH FOUNDATION PO BOX 800334 HOSPITAL WEST 6171E CHARLOTTESVILLE VA 22908 412097394 501(C)(3) 666667 TEAM SCIENCE AWARD AND YOUNG INVESTIGATOR AWARDS JOHN WAYNE CANCER INSTITUTE 2200 SANTA MONICA BOULEVARD SANTA MONICA CA 90404 954291515 501(C)(3) 666666 TEAM SCIENCE AWARDS RHODE ISLAND HOSPITAL 593 EDDY STREET PROVIDENCE RI 02903 050258954 501(C)(3) 500000 TEAM SCIENCE AWARD THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE 445 N FIFTH STREET PHOENIX AZ 85004 753065445 501(C)(3) 500000 TEAM SCIENCE AWARD JOHNS HOPKINS UNIVERSITY 733 NORTH BROADWAY BALTIMORE MD 21205 520595110 501(C)(3) 612500 TEAM SCIENCE AWARDS AND ESTABLISHED INVESTIGATOR AWARD H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE 12902 MAGNOLIA DRIVE TAMPA FL 33612 592451713 501(C)(3) 383333 TEAM SCIENCE AWARD AND PILOT AWARD DANA-FARBER CANCER INSTITUTE 44 BINNEY STREET BOSTON MA 02115 042263040 501(C)(3) 373906 TEAM SCIENCE AWARD AND ESTABLISHED INVESTIGATOR AWARD YALE UNIVERSITY 47 COLLEGE STREET NEW HAVEN CT 06520 060646973 501(C)(3) 333333 TEAM SCIENCE AWARD NEW YORK UNIVERSITY 550 FIRST AVENUE NEW YORK NY 10016 135562308 501(C)(3) 216666 TEAM SCIENCE AWARD AND YOUNG INVESTIGATOR AWARD UNIVERSITY OF CALIFORNIA BOX 0808 SAN FRANCISCO CA 94143 946036493 PUBLIC UNIVERSITY 112500 ESTABLISHED INVESTIGATOR AWARDS FRED HUTCHINSON CANCER RESEARCH CENTER 1100 FAIRVIEW AVENUE N SEATTLE WA 98109 237156071 501(C)(3) 175000 ESTABLISHED INVESTIGATOR AWARDS REGENTS UNIVERSITY OF CALIFORNIA LOS ANGELES 11000 KINROSS AVENUE SUITE 102 LOS ANGELES CA 90095 956006143 PUBLIC UNIVERSITY 166666 TEAM SCIENCE AWARD UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE BOULEVARD UNIT 1374 HOUSTON TX 77030 174601118 501(C)(3) 150000 YOUNG INVESTIGATOR AWARD AND ESTABLISHED INVESTIAGTOR AWARD THE UNIVERSITY OF CHICAGO 5801 SOUTH ELLIS AVENUE CHICAGO IL 60637 362177139 501(C)(3) 125000 ESTABLISHED INVESTIGATOR AWARD BETH ISRAEL DEACONESS MEDICAL CENTER 330 BROOKLINE AVENUE BOSTON MA 02215 042103881 501(C)(3) 112500 ESTABLISHED INVESTIGATOR AWARD STANFORD UNIVERSITY 301 RAVENSWOOD AVENUE 2ND FLOOR MENLO PARK CA 94025 941156365 501(C)(3) 50000 YOUNG INVESTIGATOR AWARD UNIVERSITY OF UTAH 2000 CIRCLE OF HOPE SALT LAKE CITY UT 84112 187600525 PUBLIC UNIVERSITY 50000 PILOT AWARD UNIVERSITY OF MICHIGAN 1400 EAST MEDICAL CENTER DRIVE ANN ARBOR MI 48109 386006309 PUBLIC UNIVERSITY 50000 YOUNG INVESTIGATOR AWARD MAYO CLINIC ROCHESTER 200 FIRST STREET SW ROCHESTER MN 55905 416011702 501(C)(3) 50000 DEVELOPMENT AWARD NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION 4150 CLEMENTS STREET 151 NC SAN FRANCISCO CA 94121 943084159 501(C)(3) 50000 PILOT AWARD 20 0 PROCEDURE FOR MONITORING GRANTS IN THE U.S.: PART I, LINE 2: SCHEDULE I, PART I, LINE 2: ALL MRA-FUNDED INVESTIGATORS AND THEIR INSTITUTIONS MUST AGREE TO PERFORM THE RESEARCH PROPOSAL IN FULL COMPLIANCE WITH ALL APPLICABLE LAWS AND REGULATIONS; THE TERMS AND CONDITIONS OF THE MRA REQUEST FOR PROPOSALS; THE REQUIREMENTS OF THE MRA TERMS AND CONDITIONS; AND THE TERMS AND CONDITIONS OF THE RESEARCH PROPOSAL. AT ANY TIME DURING THE AWARD PERIOD, AWARDEES MUST NOTIFY AND MRA MUST APPROVE ANY SIGNIFICANT CHANGES TO THE RESEARCH PROPOSAL INCLUDING RESEARCH PLAN, BUDGET, AND PERSONNEL. AWARDEES PROVIDE MRA WITH ANNUAL WRITTEN REPORTS OF THEIR RESEARCH PROGRESS AND COMPLIANCE WITH BUDGET GUIDELINES. FUNDS ARE DISTRIBUTED IN ANNUAL INSTALLMENTS AND NEXT YEAR'S INSTALLMENT IS NOT PROVIDED UNTIL SATISFACTORY REVIEW BY THE MRA CHIEF SCIENCE OFFICER AND SCIENTIFIC PROGRAM DIRECTOR. AWARDEES MUST KEEP SYSTEMATIC AND COMPLETE RECORDS ON THE RECEIPT AND DISBURSEMENT OF ALL AWARD FUNDS, AND MAY NOT CO-MINGLE ANY FUNDS FROM OTHER SOURCES. X X X X X 0 0 0 0 0 0 0 0 0 MICHAEL KLOWDEN 0 419861 0 0 0 0 0 2450 0 9373 0 431684 0 0 WENDY SELIG 232888 0 0 0 0 0 2450 0 9711 0 245049 0 0 0 KAMYAB HASHEMI-NEJAD 0 150180 0 0 0 0 0 1700 0 8947 0 160827 0 0 DEBRA LEON BLACK SEE DESCRIPTION BELOW 160386 A SCIENTIFIC RETREAT WAS HELD IN LAS VEGAS, NEVADA. IN LIGHT OF THE FAVORABLE ECONOMIC TERMS MRA WOULD RECEIVE RELATED TO THE USE OF THE FACILITIES, WHICH WAS CONFIRMED BY A REVIEW OF COSTS FOR COMPARABLE FACILITIES AND SERVICES AT OTHER VENUES, THE BOARD APPROVED THE TRANSACTION. BEFORE THIS APPROVAL, THE BOARD WAS INFORMED OF AND DISCUSSED THE FACT THAT APOLLO MANAGEMENT (AN ENTITY IN WHICH MR. BLACK HAS A SIGNIFICANT INTEREST) HAS AN ECONOMIC INTEREST IN CAESAR'S PALACE, THE LOCATION OF THE RETREAT. BOARD MEMBERS HAD FELT SUCH A CONFLICT DID NOT PRESENT ANY DIFFICULTY IN LIGHT OF THE FAVORABLE ECONOMIC TERMS MRA RECEIVED RELATED TO THE USE OF THE FACILITIES. THE MINUTES OF THE FEBRUARY 26, 2010 MEETING REFLECT BOARD APPROVAL OF THE TRANSACTION WHAT HAD BEEN DISCUSSED AND APPROVED IN A 2009 BOARD MEETING, WITH MR. AND MRS. BLACK ABSTAINING FROM THE VOTE OF THE TRANSACTION. 0 SCHEDULE L, PART IV, COLUMN B RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: LEON BLACK IS THE CHIEF EXECUTIVE OFFICER OF APOLLO MANAGEMENT, AN ENTITY THAT MANAGES INVESTMENT PARTNERSHIPS THAT OWN EQUITY INTERESTS IN CAESAR'S PALACE X 2 620000 FAIR MARKET VALUE X 3 501755 PROCEEDS X 2 3500 DONOR'S VALUE X PRINTING 2 5712 DONOR'S VALUE X GIFT BAGS 8 29410 DONOR'S VALUE X AUCTION ITEMS 14 180000 FAIR MARKET VALUE 0 0 0 FORM 990, PART VI, SECTION A, LINE 2 DEBRA BLACK AND LEON BLACK HAVE A FAMILY RELATIONSHIP. DEBRA BLACK AND RICHARD RESSLER HAVE A FAMILY RELATIONSHIP. JAMI GERTZ AND DEBRA BLACK HAVE A FAMILY RELATIONSHIP. FORM 990, PART VI, SECTION B, LINE 11 MRAF'S CEO AND TREASURER JOINTY REVIEW THE FORM 990. THE FINAL DRAFT IS MADE AVAILABLE ELECTRONICALLY TO ALL THE BOARD MEMBERS BEFORE THE CEO SIGNS THE DOCUMENT AND FILES IT WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C AS STATED IN THE MRAF BYLAWS, EACH DIRECTOR, TRUSTEE, PRINCIPAL OFFICER, AND MEMBER OF A COMMITTEE OF THE BOARD IS TO SIGN A STATEMENT ANNUALLY AFFIRMING THEY HAVE RECEIVED THE CONFLICT OF INTEREST POLICY, THEY HAVE READ AND UNDERSTAND IT, AND THEY AGREE TO COMPLY WITH IT. UPON POTENTIAL CONFLICT OF INTERESTS, THE BOARD OR COMMITTEE WILL RESOLVE THE CONFLICT IN THE BEST INTEREST OF THE ORGANIZATION. FORM 990, PART VI, SECTION B, LINE 15A ACCORDING TO THE MRAF BYLAWS, MEMBERS OF THE BOARD REVIEW AND APPROVE THE MRAF CEO SALARY TO ENSURE IT IS JUST AND REASONABLE. DURING THIS ANNUAL REVIEW, THE BOARD USES COMPENSATION SURVEYS AND THE FEDERAL FORM 990 OF OTHER ORGANIZATIONS FOR COMPARABLES. THERE ARE NO OTHER OFFICERS, DIRECTORS, OR KEY EMPLOYEES THAT ARE COMPENSATED BY MRAF. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. CHANGES IN NET ASSETS OR FUND BALANCES: FORM 990, PART XI, LINE 5: PRIOR PERIOD ADJUSTMENTS: -550. W-2 EMPLOYEES FORM 990, PART V, LINE 2A THE ORGANIZATION DOES NOT ISSUE ANY W-2S FOR THEIR EMPLOYEES. THE SUPPORTED ORGANIZATION, THE MILKEN INSTITUTE ISSUES ALL W-2S BUT EMPLOYEE COMPENSATION IS PAID BY THE MELANOMA RESEARCH ALLIANCE FOUNDATION ITSELF. THE MILKEN INSTITUTE 1250 FOURTH STREET SANTA MONICA CA 90401 954240775 EDUCATIONAL, ECONOMIC RESEARCH, HEALTHCARE RESEARCH CA 501(C)(3) LINE 7 N/A 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 THE MILKEN INSTITUTE J 123288 RENTAL EXPENSE PER SUBLEASE THE MILKEN INSTITUTE O 604311 CASH TRANSFERRED TO REIMBURSE EXP